MDT
83.58
-0.61%↓
VEEV
225.8
+0.45%↑
A
105.71
+0.08%↑
WBA
10.98
-0.18%↓
CHE
548.09
-0.97%↓
MDT
83.58
-0.61%↓
VEEV
225.8
+0.45%↑
A
105.71
+0.08%↑
WBA
10.98
-0.18%↓
CHE
548.09
-0.97%↓
MDT
83.58
-0.61%↓
VEEV
225.8
+0.45%↑
A
105.71
+0.08%↑
WBA
10.98
-0.18%↓
CHE
548.09
-0.97%↓
MDT
83.58
-0.61%↓
VEEV
225.8
+0.45%↑
A
105.71
+0.08%↑
WBA
10.98
-0.18%↓
CHE
548.09
-0.97%↓
MDT
83.58
-0.61%↓
VEEV
225.8
+0.45%↑
A
105.71
+0.08%↑
WBA
10.98
-0.18%↓
CHE
548.09
-0.97%↓
24h
Praegune
Min
7.06
Max
7.55
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +31.58% upside |
Järgmine tulemuste avaldamine | 7. mai 2025 |
---|
By Trading Central
Kindlus
Very Strong Bullish Evidence
6.17 / N/A Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
7. märts 2025, 21:54 UTC
Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring
DJ
Loe
16. jaan 2025, 16:17 UTC
Atara Shares Sink After FDA Stalls Cancer Treatment
DJ
Loe
16. jaan 2025, 14:31 UTC
FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 10 USD 31.58%
Kõrge 17 USD
Madal 3 USD
Põhineb 4 Wall Streeti analüütiku instrumendi Atara Biotherapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
4 ratings
2
Osta
2
Hoia
0
Müü
Põhineb 4 analüütiku instrumendi Atara Biotherapeutics Inc aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Keskpikk perspektiiv
Weak Bullish Evidence
Recent bullish events outweigh bearish events.
Pikk perspektiiv
Strong Bearish Evidence
All events are bearish.
$